20d
PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial
PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”) , a clinical-stage specialty pharmaceutical company focused on reformulating established therapeutics for post-operative pain management, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results